Ginkgo Bioworks (NYSE:DNA) Trading Up 6.4% – Here’s What Happened

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) shares rose 6.4% on Wednesday . The company traded as high as $12.20 and last traded at $12.32. Approximately 122,556 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 1,278,910 shares. The stock had previously closed at $11.58.

Ginkgo Bioworks Stock Performance

The firm has a market cap of $733.44 million, a P/E ratio of -0.98 and a beta of 1.09. The business has a 50-day moving average of $9.49.

Hedge Funds Weigh In On Ginkgo Bioworks

A number of large investors have recently made changes to their positions in DNA. AQR Capital Management LLC acquired a new stake in shares of Ginkgo Bioworks during the 2nd quarter valued at approximately $3,391,000. Renaissance Technologies LLC purchased a new position in Ginkgo Bioworks in the 2nd quarter valued at approximately $2,128,000. XTX Topco Ltd acquired a new position in Ginkgo Bioworks during the second quarter worth $312,000. Mackenzie Financial Corp purchased a new stake in Ginkgo Bioworks during the second quarter worth $251,000. Finally, Erste Asset Management GmbH acquired a new stake in Ginkgo Bioworks in the third quarter valued at $4,075,000. Hedge funds and other institutional investors own 78.63% of the company’s stock.

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.